3.7. KV Showed an Antiproliferative Effect and Enhanced the Anticancer Effects of Oxaliplatin in KRAS-Mutated Patient-Derived Pancreatic Cancer Organoids. This evidence concerns the gene KRAS and pancreatic neoplasm.